Society for Translational Oncology

Society for Translational Oncology Our mission is to promote high-quality, equitable healthcare through innovative education and collaborative global efforts.

STO advances global oncology and patient care by bridging scientific discovery and clinical application, promoting equitable healthcare, and harmonizing cancer trials and regulatory standards to ensure swift access to life-saving treatments worldwide. Society for Translational Oncology: A Global Mission
The Society for Translational Oncology (STO), a 501(c)(3) not-for-profit organization, is dedicated to advancing global oncology and improving patient care by bridging the gap between scientific discovery and clinical application. Committed to diversity, inclusivity, and equity, STO empowers healthcare professionals with the knowledge and tools to implement cutting-edge cancer therapies and improve patient outcomes worldwide. Through strategic guidance and global alliances, we work to harmonize cancer clinical trials and regulatory standards, ensuring that life-saving treatments are speedily accessible to all patients with cancer. STO Continuing Medical Education Mission
STO is committed to providing impactful education to oncology physicians, with the goal of improving the quality and safety of care for patients with cancer. This mission will be fulfilled by offering relevant and effective continuing medical education programs, focusing on:
Knowledge and strategies for implementation of critical new developments in cancer treatment, screening, and prevention
The translational gap between research, discovery and delivery of care to the patient, providing content that is evidence-based and within the discipline of clinical medicine
Educational activities that are relevant and impact the practice of physicians within an oncology team in collaboration with nurses, pharmacists and other oncology healthcare professionals

A recent study shows that telehealth interventions tailored for older adults with cancer can significantly improve clini...
06/23/2025

A recent study shows that telehealth interventions tailored for older adults with cancer can significantly improve clinical outcomes including lower treatment toxicity and improved survival.
This reinforces the value of geriatric assessments and personalized care even when delivered virtually.

đź“– Read more: https://www.healio.com/news/hematology-oncology/20250612/telehealth-program-significantly-improves-outcomes-for-older-adults-with-cancer

A telehealth-based intervention program helped older adults with metastatic cancer improve their physical function, mood and quality of life compared with standard care, according to results of a randomized trial.The investigation, conducted with patients from Brazil, showed Geriatric Assessment-Gui...

Symptom-assessment intervention may improve care, reduce costs for older adults with cancer A study presented at the ASC...
06/05/2025

Symptom-assessment intervention may improve care, reduce costs for older adults with cancer

A study presented at the ASCO 2025 Annual Meeting demonstrates that a proactive symptom assessment intervention, involving weekly check-ins by trained lay health workers, significantly reduces acute care utilization among older adults with cancer. Patients receiving this intervention experienced fewer emergency department visits and hospitalizations, leading to an average cost saving of $12,000 per patient. This approach underscores the value of integrating low-cost, scalable interventions to enhance care quality and reduce expenditures in geriatric oncology.

CHICAGO — A weekly symptom-assessment intervention led by trained lay health workers may help reduce acute care use and improve end-of-life care for older adults with cancer, according to data presented at ASCO Annual Meeting.Such an approach could help these patients avoid frequent and costly...

“Taking care and offering somebody a clinical trial takes more time, more effort—and that’s not necessarily reflected in...
04/30/2025

“Taking care and offering somebody a clinical trial takes more time, more effort—and that’s not necessarily reflected in clinical productivity.”

At this year’s meeting, the PAACT study shared eye-opening interviews with healthcare professionals about why many Black/African American patients still don’t have access to cancer clinical trials.

From mistrust and implicit bias to time burdens and lack of support—there’s a lot to fix. But PAACT has a roadmap. And PAACT 2.0 is already putting it to the test.

Let’s support inclusive, patient-centered research.

Home to the journal Oncology, Cancer Network provides research and opinion on the screening, early detection, diagnosis, treatment, and prevention of cancers.

Understanding Motives Behind Participation in Cancer Clinical Trials https://buff.ly/4aJRkHcExploring the motivations fo...
02/01/2025

Understanding Motives Behind Participation in Cancer Clinical Trials https://buff.ly/4aJRkHc

Exploring the motivations for participating in cancer clinical trials reveals a complex interplay of factors. Participants often join these studies driven by the hope of accessing cutting-edge treatments or contributing to scientific advancements that may benefit future patients. Understanding these motives can improve recruitment strategies and enhance the overall success of clinical trials.

Recent survey study of 978 cancer patients and their relatives uncovered reasons behind their willingness, or lack thereof, to participate in clinical research.

Baseline Geriatric Assessment and QOL Impact Chemotherapy Survival in Pancreatic Cancer https://buff.ly/3Q0bPWg
01/31/2025

Baseline Geriatric Assessment and QOL Impact Chemotherapy Survival in Pancreatic Cancer https://buff.ly/3Q0bPWg

Cervical cancer is preventable, sexually transmitted, and highly curable—even in late stages. This interview, Prof. Bell...
01/31/2025

Cervical cancer is preventable, sexually transmitted, and highly curable—even in late stages. This interview, Prof. Bello Abubakar shares key insights on prevention, education, and emerging technologies like liquid biopsy. https://buff.ly/3E8sHaN

Key Strategies to Promote Professional Wellness and Reduce Burnout in Oncology Clinicians | JCO Oncology Practice https:...
01/31/2025

Key Strategies to Promote Professional Wellness and Reduce Burnout in Oncology Clinicians | JCO Oncology Practice https://buff.ly/40DAuoB

Understanding the Cervical Cancer Crisis: Insights from Professor Lola AdeyemiCervical cancer is the second most common ...
01/30/2025

Understanding the Cervical Cancer Crisis: Insights from Professor Lola Adeyemi

Cervical cancer is the second most common cancer among women worldwide, yet it remains one of the most preventable. So why does it continue to claim so many lives? The answer lies in gaps in awareness, education, and access to screening—barriers that disproportionately affect underserved communities.

In a thought-provoking discussion with Professor Lola Adeyemi, a physician, entrepreneur, and advocate for health equity, she shared key strategies for closing these gaps and advancing cervical cancer prevention. As the Co-founder and COO of Magna Carta Health, she is leveraging technology-driven solutions to transform preventative healthcare in Nigeria.

Key Takeaways from the Conversation:
- Awareness is everything—many people either don’t know, don’t understand, or don’t prioritize cervical cancer prevention.
- Access to screening remains a major challenge, and self-testing kits offer a promising solution to expand reach.
- Technology can transform education, ensuring healthcare professionals and communities have the information they need at their fingertips.

Read the interview here: https://buff.ly/3WuXbtO

HPV testing, self-sampling kits, and single-visit treatments are transforming cervical cancer care. Prof. Rose Anorlu di...
01/29/2025

HPV testing, self-sampling kits, and single-visit treatments are transforming cervical cancer care. Prof. Rose Anorlu discusses the urgent need for education, community engagement, and innovation in screening.

Insights from Professor Rose Ihuoma Anorlu Cervical cancer remains a pressing global health challenge, particularly in low- and middle-income countries (LMICs) where disparities in prevention…

Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advance...
01/25/2025

Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer https://buff.ly/3Qa400B

Geriatric assessment, which is recommended by national guidelines, remains underutilized. One barrier is translating numerous multi-dimensional results into a clinically relevant summary score. Researchers found that for older adults with advanced non-small cell lung cancer, a deficit-accumulation frailty index can synthesize geriatric assessment results and identify patients at risk for poor OS, functional decline, hospitalization, and hematologic toxicities who may be missed by conventional performance status assessment. Integration of pretreatment frailty assessment into clinical workflows may help oncologists better identify older adults at risk for poor outcomes to optimize decision-making and supportive care.

Understanding the Cervical Cancer Crisis In her interview with STO, Prof. Lola Adeyemi, a globally recognized advocate f...
01/24/2025

Understanding the Cervical Cancer Crisis

In her interview with STO, Prof. Lola Adeyemi, a globally recognized advocate for health equity, shares powerful insights into cervical cancer care.

🔍 Did you know?
Cervical cancer is the second most common cancer among women worldwide—yet it’s one of the most preventable with education, vaccination, and regular screening.

✨ Highlights from the interview:
• The transformative potential of self-testing kits for underserved communities.
• How technology can revolutionize education for healthcare professionals.
• Strategies to close critical gaps in screening and care.

Read Prof. Adeyemi’s full interview now: https://buff.ly/3WuXbtO

Address

318 Blackwell Street
Durham, NC
27701

Alerts

Be the first to know and let us send you an email when Society for Translational Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Society for Translational Oncology:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram